Clinical Trial Update: First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4004280 in Healthy Participants [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of VH4004280 in healthy participants; results have been posted following…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VH4004280

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2025-07-30